Iatrogenic Infertility

Iatrogenic infertility means reduced or lost fertility caused unintentionally by medical treatment or a healthcare intervention. In men, this can happen after surgery, cancer treatment, hormone therapy, certain medications, or procedures that affect the testes, sperm production, ejaculation, or the reproductive tract. The term matters because the infertility is not from a person’s baseline health alone, but from a treatment that may have been necessary for another condition. Understanding the cause helps patients ask better questions, plan fertility preservation when possible, and pursue the right testing and treatment sooner.

At a glance
What is iatrogenic infertility?
Why it matters in men's health and fertility
Common causes of iatrogenic infertility
How medical treatment can impair male fertility
Symptoms and signs
What's normal vs what's not?
Testing and diagnosis
Temporary vs permanent causes
Treatment and management
Fertility preservation before treatment
Questions to ask your doctor
Common myths and misconceptions
Related terms and tests
Frequently asked questions
References

At a glance

Iatrogenic infertility is infertility caused by medical treatment, not by a naturally occurring reproductive condition alone.
In men, common causes include chemotherapy, radiation, pelvic or testicular surgery, testosterone therapy, anabolic steroids, and some medications.
It may be temporary or permanent, depending on the treatment, dose, duration, age, and baseline fertility.
Symptoms are often subtle. A man may feel normal but still have low sperm count, poor sperm motility, azoospermia, retrograde ejaculation, or hormonal suppression.
The main evaluation often includes a semen analysis, reproductive hormone testing, medical history, and sometimes imaging or genetic testing.
Testosterone replacement therapy can suppress sperm production by reducing pituitary signals needed for spermatogenesis, a point emphasized by the American Society for Reproductive Medicine.
Before treatments with known fertility risk, sperm banking is often the most practical fertility-preservation option for post-pubertal males, supported by ASCO fertility preservation guidance.
If fertility is affected, options may include stopping the offending medication, medical therapy, assisted reproduction, sperm retrieval, or use of previously frozen sperm.

What is iatrogenic infertility?

Iatrogenic infertility refers to infertility caused unintentionally by a medical treatment, diagnostic procedure, surgery, or prescribed medication. The word iatrogenic comes from medicine and means “caused by treatment.” In fertility care, it usually describes a situation where a therapy that was meant to help one condition ends up harming reproductive function.

In men, iatrogenic infertility can affect fertility in several ways:

Lowering or stopping sperm production
Damaging the testes or reproductive tract
Blocking sperm transport
Disrupting ejaculation
Suppressing the hormones that drive spermatogenesis
Causing sexual dysfunction that interferes with conception

This is not limited to cancer treatment. It can also happen with testosterone use, anabolic steroids, certain pelvic surgeries, treatment for prostate problems, medications for autoimmune disease or inflammatory conditions, and radiation exposure to the testes or brain. Depending on the cause, the problem may be reversible, partly reversible, or permanent.

The World Health Organization and major fertility societies recognize infertility as a medical condition, and male-factor infertility contributes to a substantial share of couple infertility worldwide. For broader infertility definitions, see the World Health Organization overview of infertility.

Why it matters in men's health and fertility

Iatrogenic infertility matters because it is, at least in some cases, predictable and preventable. A man may start a treatment focused on cancer, low testosterone, inflammatory disease, or a surgical problem without realizing that fertility could be affected months or years later. Sometimes the fertility impact is discussed clearly beforehand. Sometimes it is not.

That gap matters for a few reasons:

Timing is critical. Sperm banking is usually easiest before treatment starts.
Recovery is variable. Some men recover sperm production after treatment, while others do not.
Symptoms may be absent. A man can feel completely well and still have severe sperm abnormalities.
The path forward changes. Knowing the cause helps guide whether to wait, stop a medication, use hormone support, pursue sperm retrieval, or move to IVF or ICSI.

In men's health, this topic is especially important because some treatments marketed or prescribed for energy, muscle gain, or “low T” can reduce fertility rather than improve it. Exogenous testosterone and anabolic-androgenic steroids are classic examples. The endocrine feedback loop that supports sperm production is delicate, and outside hormones can switch it off.

Common causes of iatrogenic infertility

Many treatments can affect fertility, but the risk level differs substantially by therapy, dose, target organ, and duration. Below are some of the most important causes in men.

Chemotherapy

Chemotherapy can damage the cells in the testes that produce sperm, especially rapidly dividing germ cells. Alkylating agents are particularly well known for gonadotoxicity. The National Cancer Institute notes that some cancer treatments can affect fertility, sometimes permanently, depending on the regimen and exposure level: NCI: Fertility Issues in Boys and Men With Cancer.

Radiation therapy

Radiation directed at or near the testes, pelvis, abdomen, spine, or brain can impair fertility. Direct testicular radiation can damage spermatogenesis. Cranial radiation can also disrupt the pituitary hormones that regulate the testes. Even scatter radiation may matter depending on dose and shielding.

Surgery

Several procedures can cause infertility or subfertility, especially if they affect the testes, vas deferens, epididymis, prostate, bladder neck, or pelvic nerves. Examples include:

Testicular surgery
Inguinal or scrotal surgery that injures the vas deferens
Pelvic or retroperitoneal surgery
Prostate or bladder surgery that causes retrograde ejaculation or ejaculatory dysfunction
Hernia repair in rare cases involving ductal injury

Vasectomy is technically an iatrogenic cause of infertility because it is a medical procedure that intentionally blocks fertility, though the term is more often used for unintended fertility loss from treatment.

Testosterone therapy and anabolic steroids

External testosterone suppresses luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which can lead to marked reduction in intratesticular testosterone and impaired sperm production. The result may be oligospermia or azoospermia. This effect is well recognized in fertility and endocrine practice, including by ASRM guidance on testosterone use and male infertility.

Anabolic steroids can cause a similar or more pronounced suppression pattern, often with testicular shrinkage and prolonged recovery.

Medications

Some prescribed drugs may affect sperm production, ejaculation, erection, libido, or hormone signaling. Examples may include:

Some immunosuppressive or cytotoxic drugs
Certain hormonal therapies
Some medications for prostate symptoms that affect ejaculation
Some antidepressants or antipsychotics that may affect sexual function
Opioids, which can suppress the hypothalamic-pituitary-gonadal axis in some men

The fertility effect of a medication depends on the specific drug and individual context. Not every medication in these categories causes infertility, and some effects are sexual rather than spermatogenic.

Radioiodine and other targeted therapies

Some treatments used for thyroid disease or cancer may affect gonadal function. The degree of risk depends on the exact therapy, dose, and cumulative exposure.

Transgender hormone therapy

Gender-affirming hormone therapy can reduce sperm production. Patients considering future genetic parenthood are typically advised to discuss fertility preservation before treatment. This is addressed in fertility-preservation guidance from specialty societies such as ASRM.

How medical treatment can impair male fertility

Iatrogenic infertility is easier to understand when you break it into mechanisms. A treatment may affect one or several of these areas at the same time.

1. Testicular damage

The testes contain germ cells that develop into sperm and Leydig cells that help produce testosterone. Chemotherapy, radiation, trauma, or surgery can injure these cells directly. Damage to germ cells usually affects sperm count first, but severe injury may cause azoospermia.

2. Hormonal suppression

The brain signals the testes through gonadotropin-releasing hormone, LH, and FSH. External testosterone, anabolic steroids, and some other hormone therapies can suppress this axis. When LH and FSH fall, sperm production can slow dramatically or stop.

3. Obstruction

Sperm may be produced normally but blocked from reaching the ejaculate because of injury or scarring in the epididymis, vas deferens, ejaculatory ducts, or related structures. Surgery and inflammatory complications can cause this pattern.

4. Ejaculatory dysfunction

Some pelvic operations and some medications interfere with emission or ejaculation. In retrograde ejaculation, semen goes backward into the bladder instead of out through the urethra. That can make natural conception difficult even if sperm production is otherwise intact.

5. Sexual side effects that reduce conception chances

Infertility is not always about sperm count alone. A treatment may lower libido, impair erections, or cause fatigue severe enough to reduce sexual activity during the fertile window. Those effects do not always equal infertility, but they can contribute to delayed conception.

Symptoms and signs

Iatrogenic infertility often has no obvious symptoms. Many men discover it only after trying to conceive or after a post-treatment fertility evaluation. When symptoms do appear, they depend on the cause.

Possible signs in men

Difficulty conceiving after 12 months of unprotected intercourse, or sooner if there is a known fertility risk
Very low semen volume
No sperm seen on semen analysis
Changes in ejaculation, including dry orgasm or retrograde ejaculation
Reduced testicular size, particularly after anabolic steroid or testosterone use
Low libido or erectile dysfunction if hormones are disrupted
Symptoms of low testosterone in some cases, although testosterone can be normal even when sperm production is impaired

Because sperm production takes time, treatment-related fertility changes may not show up immediately. A typical spermatogenic cycle takes about 74 days, so semen changes may emerge weeks to months after an exposure.

What's normal vs what's not?

There is no single “normal fertility” number that rules in or rules out conception, but semen analysis gives a practical starting point. The World Health Organization provides widely used reference limits for semen parameters. A result below the reference range does not guarantee infertility, and a result in range does not guarantee fertility. It simply helps interpret risk and guide next steps.

Key semen analysis benchmarks

Parameter	Typical reference concept	What may be concerning after treatment
Semen volume	Lower reference limit commonly around 1.4 mL in WHO 6th edition context	Low volume may suggest ejaculatory dysfunction, partial obstruction, or retrograde ejaculation
Sperm concentration	Lower reference limit commonly around 16 million/mL	Low concentration may reflect testicular injury or hormonal suppression
Total motility	Lower reference limit commonly around 42%	Poor motility may reduce natural conception chances
Progressive motility	Lower reference limit commonly around 30%	Reduced forward movement can impair fertilization
Morphology	Strict criteria often use 4% normal forms as a lower reference benchmark	Abnormal forms alone do not define sterility but may matter with other abnormalities
Azoospermia	No sperm seen in ejaculate	May indicate severe suppression, testicular failure, or obstruction

For an overview of semen testing and interpretation, see the NCBI Bookshelf review on semen analysis and WHO manual resources.

Hormones: what may be abnormal?

Hormone testing often includes FSH, LH, total testosterone, estradiol, and prolactin. Patterns can help distinguish testicular damage from pituitary suppression.

High FSH may suggest impaired sperm production from primary testicular damage.
Low LH and FSH can occur with exogenous testosterone or steroid use.
Low testosterone may or may not be present.

Interpretation should be individualized, especially if testing occurs during or soon after treatment.

Testing and diagnosis

If iatrogenic infertility is suspected, the goal is to identify what part of the reproductive system was affected, whether the injury may be reversible, and what options exist now.

Core evaluation

Detailed medical history
Include cancer therapies, medication use, testosterone or steroid exposure, prior surgeries, radiation fields, timing of fertility decline, sexual symptoms, and reproductive goals.
Semen analysis
Usually at least two samples are recommended because semen parameters naturally fluctuate.
Hormone testing
Often includes FSH, LH, total testosterone, estradiol, and prolactin.
Physical exam
May assess testicular size, varicocele, vas deferens presence, signs of hormonal suppression, and secondary sexual characteristics.
Post-ejaculatory urinalysis
Useful if retrograde ejaculation is suspected.
Scrotal or transrectal ultrasound
Can help if obstruction or structural problems are suspected.
Genetic testing
Sometimes used when azoospermia or severe oligospermia is present, though this is not specific to iatrogenic cases.

How clinicians interpret the pattern

Low sperm with low LH/FSH: may point toward medication-induced central suppression, such as testosterone therapy.
Azoospermia with high FSH: may suggest severe testicular injury.
Low volume with normal hormones: may suggest ejaculatory duct obstruction or retrograde ejaculation.
Normal hormones but no sperm after surgery: obstruction may be more likely.

The American Urological Association and American Society for Reproductive Medicine provide guidance on male infertility evaluation in clinical practice: AUA/ASRM Male Infertility Guideline.

Temporary vs permanent causes

One of the most common questions is whether fertility will come back. The answer depends on the type of treatment and degree of injury.

Cause	How it affects fertility	May be temporary?	May be permanent?
Testosterone therapy	Suppresses LH/FSH and sperm production	Yes, often	Sometimes recovery is prolonged or incomplete
Anabolic steroid use	Strong hormonal suppression, possible testicular shrinkage	Yes	Possible in some cases, especially after prolonged use
Chemotherapy	Can damage germ cells directly	Sometimes	Yes, especially with gonadotoxic regimens
Testicular radiation	Direct gonadal injury	Sometimes, dose-dependent	Yes
Pelvic nerve injury surgery	Can impair ejaculation	Sometimes	Yes
Vas deferens or epididymal injury	Obstructs sperm transport	Usually not without intervention	Yes, if not repaired
Medication affecting ejaculation	May reduce semen emission or cause retrograde ejaculation	Often	Less often

These are general patterns, not guarantees. Recovery can take months because new sperm need time to develop, and some treatments cause lasting structural damage that medication cannot reverse.

Treatment and management

Management depends on the mechanism of infertility, the urgency of conception, the partner's fertility factors, and whether treatment can be modified safely.

1. Stop or change the offending therapy when medically appropriate

If fertility suppression is caused by testosterone, anabolic steroids, or a nonessential medication, stopping or switching treatment may allow recovery. This should be done under clinician supervision, not abruptly on your own.

2. Medical therapy to support recovery

Some men with hormone-related suppression may be treated with medications such as selective estrogen receptor modulators or gonadotropin-based therapy under specialist care. These treatments are not appropriate for everyone, but they may help restore endogenous hormone signaling and spermatogenesis in selected patients.

3. Treat ejaculation problems

If retrograde ejaculation or ejaculatory dysfunction is the main issue, treatment may include medication changes, bladder preparation techniques for sperm recovery, or assisted reproduction using recovered sperm.

4. Surgical repair or sperm retrieval

If obstruction is suspected, microsurgical reconstruction may be possible in some cases. When reconstruction is not feasible or time is limited, sperm may sometimes be retrieved directly from the epididymis or testes for use with IVF and intracytoplasmic sperm injection (ICSI).

5. Assisted reproductive technology

Depending on semen quality and female partner factors, options may include:

Intrauterine insemination (IUI) for mild male-factor cases
IVF
IVF with ICSI, especially when sperm count is very low or surgical retrieval is required
Use of previously cryopreserved sperm

6. Ongoing monitoring

Semen analyses are often repeated over time to look for recovery. Hormones may also be tracked if suppression or endocrine injury is involved.

For cancer survivors, follow-up care often includes reproductive counseling, particularly if future family building is a goal. Helpful patient resources are available from the National Cancer Institute.

Fertility preservation before treatment

When a treatment has a known fertility risk, the most important step is often taken before treatment begins.

Best-established option for post-pubertal males

Sperm cryopreservation, commonly called sperm banking, is the standard fertility-preservation approach for most post-pubertal males. It is recommended by major oncology and reproductive societies when gonadotoxic treatment is planned, including ASCO fertility preservation guidance.

How sperm banking typically works

Meet with a fertility clinic or andrology lab as early as possible.
Provide one or more semen samples.
The samples are analyzed, processed, and frozen.
The sperm can later be used for IUI, IVF, or IVF with ICSI depending on quality.

When ejaculation is not possible

If a semen sample cannot be produced, alternatives may include vibratory stimulation, electroejaculation, or surgical sperm retrieval depending on the situation and timing.

What if treatment already started?

It may still be worth discussing fertility options. Some men retain sperm production during treatment, and some can pursue later recovery or surgical retrieval. But in general, preservation is easiest before exposure.

Questions to ask your doctor

If you are starting a treatment that could affect fertility, or you think a past treatment may be affecting you now, these questions can help:

Does this treatment carry a risk of temporary or permanent infertility?
How likely is it to affect sperm count, ejaculation, or hormones?
Should I get a semen analysis before treatment starts?
Is sperm banking recommended in my case?
If I am on testosterone, what are my fertility-friendly alternatives?
How long should I wait after treatment before rechecking semen parameters?
Could my fertility issue be due to obstruction, hormonal suppression, or testicular damage?
Would I benefit from referral to a reproductive urologist or fertility specialist?
If my semen analysis is abnormal, what treatment options are realistic?
If recovery is unlikely, what assisted reproduction options are available?

Common myths and misconceptions

Myth: If a treatment lowers fertility, I would definitely notice symptoms.

Not true. Many men with severe sperm abnormalities feel completely normal. Semen testing is often necessary.

Myth: Testosterone therapy improves fertility because it increases testosterone.

False. External testosterone can suppress the hormones needed for sperm production and may lower fertility significantly, as emphasized by ASRM.

Myth: If infertility is treatment-related, nothing can be done.

False. Some cases recover with time or medication changes. Others can be managed with sperm retrieval, microsurgery, or assisted reproduction.

Myth: Cancer survival is the only issue that matters after treatment.

Survival is the priority, but fertility and long-term quality of life matter too. That is why pre-treatment counseling is so important.

Myth: One abnormal semen analysis proves permanent infertility.

Not necessarily. Semen quality fluctuates, and temporary suppression is possible. Repeat testing and context matter.

Azoospermia: no sperm in the ejaculate
Oligospermia: low sperm concentration
Asthenozoospermia: reduced sperm motility
Teratozoospermia: abnormal sperm morphology
Spermatogenesis: the process of making sperm
Hypogonadotropic hypogonadism: low gonadotropin signaling from the brain
Retrograde ejaculation: semen enters the bladder instead of exiting forward
Semen analysis: the core lab test for sperm count, motility, volume, and morphology
FSH and LH: pituitary hormones that regulate testicular function
ICSI: intracytoplasmic sperm injection, an IVF technique used when male-factor infertility is significant

Frequently asked questions

Can iatrogenic infertility be reversed?

Sometimes. Recovery depends on the cause. Hormonal suppression from testosterone therapy may improve after stopping treatment, while severe testicular damage from chemotherapy or radiation may be permanent.

Is testosterone replacement therapy a cause of male infertility?

Yes. External testosterone can suppress LH and FSH, which are required for normal sperm production. Some men develop very low sperm counts or azoospermia while using it.

How long does it take sperm to recover after stopping testosterone or steroids?

Recovery varies. Some men improve over several months, while others take longer. Because sperm development takes time, improvement is not immediate. Specialist follow-up is often helpful.

Can chemotherapy cause permanent infertility in men?

Yes, it can. The risk depends on the drug, dose, cumulative exposure, and baseline fertility. Some men recover sperm production, but others do not.

What test confirms iatrogenic infertility?

There is no single test that confirms the diagnosis by itself. The diagnosis usually relies on history plus findings from semen analysis, hormone testing, and sometimes imaging or post-ejaculatory urine testing.

What is the difference between infertility and sterility?

Infertility usually means difficulty achieving pregnancy after a period of trying. Sterility implies an inability to conceive naturally at all. Many treatment-related fertility problems fall somewhere in between and may still be treatable.

Can surgery cause infertility even if testosterone levels stay normal?

Yes. Surgery can cause obstruction or ejaculatory problems without necessarily lowering testosterone. A man may have normal hormone levels but still have no sperm in the semen.

Should men bank sperm before cancer treatment?

In many cases, yes. Sperm banking is a standard fertility-preservation option for post-pubertal males facing treatments that may harm fertility. It is best done before treatment starts.

Does a normal sex drive mean fertility is normal?

No. Libido and fertility are not the same thing. A man can have normal sexual function and still have low sperm count or azoospermia.

When should I see a reproductive urologist?

If you have a history of chemotherapy, radiation, testosterone use, anabolic steroid use, pelvic or testicular surgery, or abnormal semen results, a reproductive urologist is often the right specialist to see.